参考文献/References:
[1] 朱远群.非黏附性液体栓塞材料ONYX与脑动静脉畸形的治疗[J].中国组织工程研究与临床康复,2010,14:3891.
Zhu YQ.Non-adhesive liquid embolic material ONYX treatment of cerebral arteriovenous malformations[J].J Clin Rehabil Tissue Eng Res,2010,14:3891.
[2]Vollherbst DF,Chapot R,Bendszus M,et al.Glue,Onyx,Squid or PHIL? Liquid embolic agents for the embolization of cerebral arteriovenous malformations and dural arteriovenous fistulas[J].Clin Neuroradiol,2022,32:29-33.
[3]徐敬晨,尹毅霞,黄海能,等.Glubran胶和Onyx胶栓塞治疗颅内小型动静脉畸形的临床研究[J].右江民族医学院学报,2023,45:791-792.
Xu JC,Yin YX,Huang HN,et al.Clinical study of glubran and onyx glue embolization in the treatment of intracranial small arteriovenous malformation[J].J Youjiang Med Univ Nationalities,2023,45:791-792.
[4]Minici R,Venturini M,Fontana F,et al.Efficacy and safety of ethylene-vinyl alcohol(EVOH)copolymer-based non-adhesive liquid embolic agents(NALEAs)in transcatheter arterial embolization(TAE)of acute non-neurovascular bleeding:a multicenter retrospective cohort study[J].Medicina(Kaunas),2023,59:709-711.
[5]Murayama Y,Vinuela F,Ulhoa A,et al.Nonadhesive liquid embolic agent for cerebral arteriovenous malformations:preliminary histopathological studies in swine rete mirabile[J].Neurosurgery,1998,43:1164-1165.
[6]Panagiotopoulos V,Gizewski E,Asgari S,et al.Embolization of intracranial arteriovenous malformations with ethylene-vinyl alcohol copolymer(Onyx)[J].AJNR Am J Neuroradiol,2009,30:99-102.
[7]Ayad M,Eskloglu E,Mericle RA.Onyx:a unique neuroembolic agent[J].Expert Rev Med Devices,2006,3:708.
[8]温玉东,魏建军.Onyx在脑动静脉畸形中应用进展[J].介入放射学杂志,2010,19:922.
Wen YD,Wei JJ.The advances in applying Onyx for the treatment of cerebral arteriovenous malformations[J].J Interv Radiol,2010,19:2.
[9]Rubio-García JJ,Mantilla Pinilla AJ,Gil Sanchez S,et al.Onyx,a new tool for intraoperative localization of liver lesions[J].Surg Innov,2024,31:220.
[10]Palavani LB,Camerotte R,Mitre LP,et al.Evaluating the Potential of Pre-Embolization using EVOH(Onyx and Squid)in Carotid Body Tumor Paraganglioma[J].World Neurosurg,2024:487-488.
[11]Petrov A,Ivanov A,Kolomin E,et al.The Advantages of Non-Adhesive Gel-like Embolic Materials in the Endovascular Treatment of Benign Hypervascularized Lesions of the Head and Neck[J].Gels,2023,9:955-956,966.
[12]Perri P,Sena G,Piro P,et al.Onyx TMGel or Coil versus Hydrogel as embolic agents in endovascular applications:review of the literature and case series[J].Gels,2024,10:314.
[13]Ch'ng LS,Zaki Z,Muda AS.Embolization of brain arteriovenous malformations with squid co-polymer embolic material:Initial experience[J].J Interv Med,2023,6:177-178.
[14]Piacentino F,Fontana F,Curti M,et al.Non-adhesive liquid embolic agents in extra-cranial district:state of the art and review of the literature[J].J Clin Med,2021,10:4842-4843.
[15]韦德华,彭 晖,蔡跃豪.液体栓塞剂 Onyx 在脑动静脉畸形栓塞术中的安全性及疗效[J].医学食疗与健康,2021,019:69-70.
Wei DH,Peng H,Cai YH.Safety and efficacy of the liquid embolic agent Onyx in the embolization of brain arteriovenous malformations[J].Med Diet Health,2021,19:69-70.
[16]Cheung EYH,Ng RYT,Yu SCH,et al.PHIL and squid embolization of cerebral arteriovenous malformation:a retrospective case series of 23 patients[J].Neurointervention,2022,17:175,178-179.
[17]Schmitt N,Wucherpfennig L,Hohenstatt S,et al.Visibility of liquid embolic agents in fluoroscopy:a systematic in vitro study[J].J Neurointerv Surg,2023,15:594,598.
[18]Vollherbst DF,BoppelT,Wallocha M,et al.LIQUID-Treatment of high-grade dural arteriovenous fistulas with Squid liquid embolic agent:a prospective,observational multicenter study[J].J Neurointerv Surg,2023,15:1115-1116.
[19]Ahmad S,Uddin M.Peripheral arteriovenous malformation embolization using squid[J].Case Rep Vasc Med,2023,2023:7.
[20]Gioppo A,Farago G,Caldiera V,et al.Medial tentorial dural arteriovenous fistula embolization:single experience with embolic liquid polymer SQUID and review of the literature[J].World Neurosurgery,2017,107:1054.
[21]Vollherbst DF,Otto R,Hantz M,et al.Investigation of a new version of the liquid embolic agent PHIL with extra-low-viscosity in an endovascular embolization model[J].AJNR Am J Neuroradiol,2018,39:1699-1700.
[22]Akmangit I,Daglioglu E,Kaya T,et al.Preliminary experience with squid:a new liquid embolizing agent for AVM,AV fistulas and tumors[J].Turkish neurosurgery,2014,24:565-566.
[23]Prashar A,Butt S,Shaida N.Introducing PHIL(precipitating hydrophobic injectable liquid)-a new embolic agent for the body interventional radiologist[J].Diagn Interv Radiol,2020,26:140,142.
[24]Samaniego EA,Derdeyn CP,Hayakawa M,et al.In vivo evaluation of the new PHIL low viscosity in a swine rete mirabile model[J].Interv Neuroradiol,2018,24:707-708,711.
[25]Giurazza F,Cionfoli N,Paladini A,et al.PHIL(precipitating hydrophobic injectable liquid):Retrospective multicenter experience on 178 patients in peripheral embolizations[J].Radiol Med,2022,127:1303-1304.
[26]Hu J,Albadawi H,Chong BW,et al.Advances in biomaterials and technologies for vascular embolization[J].Adv Mater,2019,31:30-31.
[27]Leyon JJ,Chavda S,Thomas A,et al.Preliminary experience with the liquid embolic material agent PHIL(Precipitating Hydrophobic Injectable Liquid)in treating cranial and spinal dural arteriovenous fistulas[J].J Neurointerv Surg,2016,8:598,601-602.
[28]Kocer N,Hanmoglu H,Batur S,et al.Preliminary experience with precipitating hydrophobic injectable liquid in brain arteriovenous malformations[J].Diagn Interv Radiol,2016,22:184,188.
[29]Sirakov SS,Sirakov A,Minkin K,et al.Initial experience with precipitating hydrophobic injectable liquid in cerebral arteriovenous malformations[J].Interv Neuroradiol,2019,25:58-59.
[30]Vollherbst DF,Sommer CM,Ulfert C,et al.Liquid embolic agents for endovascular embolization:evaluation of an established(Onyx)and a novel(PHIL)embolic agent in an In Vitro AVM model[J].AJNR Am J Neuroradiol,2017,38:1377,1381.
[31]Kulcsár Z,Karol A,Kronen PW,et al.A novel,non-adhesive,precipitating liquid embolic implant with intrinsic radiopacity:feasibility and safety animal study[J].Eur Radiol,2017,27:1248-1251.
[32]Dudeck O,Jordan O,Hoffmann KT,et al.Embolization of experimental wide-necked aneurysms with iodine-containing polyvinyl alcohol solubilized in a low-angiotoxicity solvent[J].AJNR Am J Neuroradiol,2006,27:1849-1850,1853-1854.
[33]Pal A,Blanzy J,Gomez KJR,et al.Liquid embolic agents for endovascular embolization:a review[J].Gels,2023,9:3-5,387,393.
[34]Leati G,Di Bartolomeo F,Maffi G,et al.Translumbar type Ⅱ endoleak embolization with a new liquid iodinated polyvinyl alcohol polymer:Case series and review of current literature[J].Front Radiol,2023,3:1,5-6.
[35]Sapoval M,Vidal V,Déan C,et al.Safety and efficacy of peripheral embolization with EASYX liquid embolic agent:a multicenter prospective study[J].J Vasc Interv Radiol,2021,32:1137,1140-1141.
[36]Dudeck O,Jordan O,Hoffmann KT,et al.Intrinsically radiopaque iodine-containing polyvinyl alcohol as a liquid embolic agent:evaluation in experimental wide-necked aneurysms[J].J Neurosurg,2006,104:292-294.
[37]Llibre-Guerra JC,Guimaraens L,Kadziolka KB,et al.ihtObtura:a novel liquid embolic agent with post-embolization radiopacity loss,in endovascular treatment of brain arteriovenous malformations,dural arteriovenous fistulas,and tumors:CLARIDAD trial[J].J Neurointerv Surg,2024,17:493-498.
[38]Catapano JS,Frisoli FA,Nguyen CL,et al.Spetzler-Martin grade Ⅲ arteriovenous malformations:a multicenter propensity-adjusted analysis of the effects of preoperative embolization[J].Neurosurgery,2021,88:999-1000.
[39]Luzzi S,Maestro M,Bongetta D,et al.Onyx embolization before the surgical treatment of grade Ⅲ spetzler-martin brain arteriovenous malformations:single-center experience and technical nuances[J].World Neurosurgery,2018,116:340-341.
[40]Dudeck O,Jordan O,Hoffmann KT,et al.Organic solvents as vehicles for precipitating liquid embolics:a comparative angiotoxicity study with superselective injections of swine rete mirabile[J].AJNR Am J Neuroradiol,2006,27:1900,1902-1904.
[41]Zhou F,Chen L,An Q,et al.Novel hydrogel material as a potential embolic agent in embolization treatments[J].Sci Rep,2016,6:3,8.
(收稿日期:2025-04-21)
(本文编辑:新 宇)
相似文献/References:
[1]石 潆,赵 卫,沈 进,等.脑动静脉畸形栓塞治疗术并发颅内出血的原因及处理[J].介入放射学杂志,2012,(03):185.
,,et al.Ｉｎｔｒａｃｒａｎｉａｌ ｈｅｍｏｒｒｈａｇｅ ｄｕｅ ｔｏ ｅｍｂｏｌｉｚａｔｉｏｎ ｔｈｅｒａｐｙ ｆｏｒ ｃｅｒｅｂｒａｌ ａｒｔｅｒｉｏｖｅｎｏｕｓ ｍａｌｆｏｒｍａｔｉｏｎ： ｉｔｓ ｃａｕｓｅｓ ａｎｄ ｍａｎａｇｅｍｅｎｔ [J].J Intervent Med,2012,(04):185.
[2]高爱荣,孙丰敏.血管内栓塞治疗脑动静脉畸形的护理[J].介入放射学杂志,2000,(03):138.
[3]李强,洪波,刘建民.２００９世界神经外科和神经介入大会掠影[J].介入放射学杂志,2010,(02):154.
LI Qiang,HONG Bo,LIU Jianmin.A glance at Live Interventional Neuroradiology＆Neurosurgery Course２００９[J].J Intervent Med,2010,(04):154.
[4]萧承江,王颂章.56例脑动静脉畸形真丝栓塞治疗[J].介入放射学杂志,1994,(01):18.
[5]屈传强,李彩霞.乙烯-乙燃基醇共聚物在脑动静脉畸形治疗中的研究进展[J].介入放射学杂志,2006,(01):60.
QU Chuan-qiang,LI Cai-xia.Advancement of ethylene vinyl alchohol copolymer in the treatment of cerebral arteriovenous malformation[J].J Intervent Med,2006,(04):60.
[6]陈覃,郭秀元,司宪平,等.颅内血管病的介入栓塞治疗(附13例报告)[J].介入放射学杂志,1996,(04):218.
[7]邢丽,杨进全.脑动静脉畸形介入治疗的配合与护理[J].介入放射学杂志,1996,(04):230.
[8]温玉东,魏建军.Ｏｎｙｘ在脑动静脉畸形中应用进展[J].介入放射学杂志,2010,(11):921.
WEN Yu-dong,WEI Jian-jun.. The advances in applying Onyx for the treatment of cerebral arteriovenous malformations[J].J Intervent Med,2010,(04):921.
[9]万军,张晓龙,鲁刚,等.颅内破裂囊状动脉瘤的血管内介入治疗[J].介入放射学杂志,2010,(11):847.
WAN Jun,ZHANG Xiao-long,LU Gang,et al.Endovascular treatment of ruptured saccular intracranial aneurysms[J].J Intervent Med,2010,(04):847.
[10]祖庆泉,施海彬,杨正强,等.永久性颗粒栓塞治疗大咯血[J].介入放射学杂志,2011,(02):108.
ZU Qing-quan,SHI Hai-bin,YANG Zheng-qiang,et al.Bronchial artery embolization by using permanent particles for the treatment of massive hemoptysis[J].J Intervent Med,2011,(04):108.
[11]郭宏磊,朱 杰,何 波,等.Onyx－１８栓塞治疗脑动静脉畸形２８例临床分析[J].介入放射学杂志,2011,(02):145.
GUO Hong-lei,ZHU Jie,HE Bo,et al.Embolization treatment of cerebral arteriovenous malformations with Onyx-18: a clinical analysis[J].J Intervent Med,2011,(04):145.